Valuation: Faes Farma, S.A.

Market Cap 1.49B 1.66B 1.37B 1.24B 2.33B 158B 2.37B 16.37B 6.52B 83.17B 6.25B 6.11B 263B P/E 2026 *
17.9x
P/E 2027 * 13.8x
Enterprise Value 1.77B 1.99B 1.63B 1.48B 2.78B 189B 2.83B 19.53B 7.78B 99.23B 7.45B 7.29B 313B EV / Sales 2026 *
2.42x
EV / Sales 2027 * 2.19x
Free-Float
78.08%
Yield 2026 *
2.79%
Yield 2027 * 3.4%
1 day+0.74%
1 week+0.74%
Current month+2.36%
1 month+0.10%
3 months+3.69%
6 months-0.31%
Current year-7.46%
1 week 4.62
Extreme 4.62
4.81
1 month 4.52
Extreme 4.52
5.03
Current year 4.32
Extreme 4.315
5.44
1 year 4.32
Extreme 4.315
5.44
3 years 2.89
Extreme 2.89
5.44
5 years 2.86
Extreme 2.865
5.44
10 years 2.57
Extreme 2.57
5.48
Manager TitleAgeSince
Chief Executive Officer - 01/09/2024
Director of Finance/CFO - 14/07/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 16/05/1991
Director/Board Member - 02/08/2010
Director/Board Member - 19/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
04/02/26 Others

Director

53,900 0.0170%
04/02/26 Others

Director

87,383 0.0276%
04/02/26 Sell

Director

24,000 0.0076%
Change 5-day change 1-year change 3-year change Capi.($)
+0.74%+0.74%+7.06%+65.80% 1.65B
+6.63%+8.10%+67.50%+145.20% 1,148B
+1.53%+6.76%+47.22%+89.01% 652B
+1.68%+2.10%+27.80%+109.31% 505B
+0.73%+2.47%+53.85%+68.96% 384B
+3.83%-2.37%+68.14%+42.32% 348B
+2.38%+4.27%+33.81%+57.95% 294B
+2.26%+3.47%+5.21%+28.92% 264B
+1.97%+5.11%+57.74%+76.14% 244B
+4.03%+7.84%+40.49%+116.14% 197B
Average +1.29%+1.25%+40.88%+79.98% 403.88B
Weighted average by Cap. +1.08%+1.50%+49.56%+95.96%

Financials

2026 *2027 *
Net sales 733M 821M 675M 613M 1.15B 78.04B 1.17B 8.07B 3.22B 41B 3.08B 3.01B 129B 793M 887M 730M 663M 1.24B 84.4B 1.26B 8.73B 3.48B 44.35B 3.33B 3.26B 140B
Net income 84.03M 94.04M 77.38M 70.25M 131M 8.94B 134M 925M 369M 4.7B 353M 345M 14.83B 109M 122M 100M 90.91M 170M 11.57B 173M 1.2B 477M 6.08B 457M 447M 19.2B
Net Debt 287M 322M 265M 240M 450M 30.58B 458M 3.16B 1.26B 16.07B 1.21B 1.18B 50.72B 246M 275M 227M 206M 385M 26.18B 392M 2.71B 1.08B 13.76B 1.03B 1.01B 43.42B
Projected Income Statement - Annual - Faes Farma, S.A.
Logo Faes Farma, S.A.
Faes Farma SA is a Spain-based company engaged in the pharmaceutical industry. The Company specializes in the research, production, distribution and sale of prescription and generic drugs, over-the-counter (OTC) medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The Company’s research lines are mainly focused on the development of new drugs for the treatment of allergy, venous insufficiency and irritable bowel syndrome, among others. In addition, it provides animal nutrition products. The Company operates in Spain, Portugal, Chile and Mexico, among others. It controls a number of subsidiaries, such as Laboratorios Vitoria SA, Laboratorios Veris SA, Lazlo International SA, Ingaso Farm SLU, Esfion SA and Biotecnet I MAS D SA.
Employees
2,611
Date Price Change Volume
29/10/26 €4.775 +0.74% 197,893
28/10/26 €4.740 0.00% 149,494
27/10/26 €4.740 +1.17% 107,631
26/10/26 €4.685 +1.08% 107,069
23/10/26 €4.635 -1.59% 59,402
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Faes Farma, S.A.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
4.775EUR
Average target price
5.430EUR
Spread / Average Target
+13.72%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Faes Farma, S.A.